NATERA INC (NTRA) Stock Price, Quote, News and Overview
NASDAQ:NTRA - Nasdaq - US6323071042 - Common Stock - Currency: USD
NTRA Quote, Performance and Key Statistics
NATERA INC
NASDAQ:NTRA (2/5/2025, 11:35:59 AM)
176.21
+1.97 (+1.13%)
The current stock price of NTRA is 176.21 USD. In the past month the price increased by 3.96%. In the past year, price increased by 149.84%.
NTRA Latest News, Press Releases and Analysis
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).
Exploring high growth characteristics of NATERA INC (NASDAQ:NTRA). A fundamental and technical analysis of (NASDAQ:NTRA).
Natera Announces National Commercial Coverage for its Fetal RhD NIPT
Natera to Present New Data at the 2025 ASCO GI Symposium
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
The company is working to expand the uses and reimbursement for its blood-based tests for cancer.
NTRA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.93 | 338.58B | ||
| AMGN | AMGEN INC | 15.34 | 163.38B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 956.11 | 125.58B | ||
| GILD | GILEAD SCIENCES INC | 22.59 | 124.74B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.48 | 77.62B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.92B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.47B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.49B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.44B | ||
| BIIB | BIOGEN INC | 8.97 | 21.34B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.72 | 15.98B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 15.79B |
Related stock screener links
About NTRA
Company Profile
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. The company is headquartered in Austin, Texas and currently employs 3,282 full-time employees. The company went IPO on 2015-07-02. Its cell-free deoxyribonucleic acid (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The firm's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening, Spectrum Preimplantation Genetics, Anora Miscarriage Test, Empower, and Prospera. The firm also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Company’s algorithms and bioinformatics in order to validate and launch tests based on the Company’s technology. Its NIPT screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother.
Company Info
NATERA INC
13011 Mccallen Pass, Building A Suite 100
Austin TEXAS 78753 US
CEO: Steve Chapman
Employees: 3282
Company Website: https://www.natera.com/
Investor Relations: https://investor.natera.com
Phone: 16502499090
NTRA FAQ
What is the stock price of NTRA?
The current stock price of NTRA is 176.21 USD.
What is the symbol for NATERA INC stock?
The exchange symbol of NATERA INC is NTRA and it is listed on the Nasdaq exchange.
On which exchange is NTRA stock listed?
NTRA stock is listed on the Nasdaq exchange.
Is NTRA a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for NTRA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of NTRA.
Does NTRA stock pay dividends?
NTRA does not pay a dividend.
When does NTRA stock report earnings?
NTRA will report earnings on 2025-02-26, after the market close.
What is the Price/Earnings (PE) ratio of NTRA?
NTRA does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.76).
What is the Short Interest ratio of NTRA stock?
The outstanding short interest for NTRA is 3.35% of its float.
NTRA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to NTRA. When comparing the yearly performance of all stocks, NTRA is one of the better performing stocks in the market, outperforming 96.54% of all stocks.
NTRA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NTRA. NTRA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
NTRA Financial Highlights
Over the last trailing twelve months NTRA reported a non-GAAP Earnings per Share(EPS) of -1.76. The EPS increased by 61.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -13.49% | ||
| ROE | -24.44% | ||
| Debt/Equity | 0.42 |
NTRA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to NTRA. The Buy consensus is the average rating of analysts ratings from 25 analysts.
For the next year, analysts expect an EPS growth of 60.23% and a revenue growth 55.75% for NTRA